• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病态肥胖患者非酒精性脂肪性肝病的谱:患病率及相关危险因素。

The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors.

作者信息

Feijó Suerda Guiomar, Lima José Milton de Castro, Oliveira Maria Aparecida Alves de, Patrocínio Régia Maria Vidal, Moura-Junior Luis Gonzaga, Campos Antônio Borges, Lima José Wellington Oliveira, Braga Lúcia Libanez Bessa Campelo

出版信息

Acta Cir Bras. 2013 Nov;28(11):788-93. doi: 10.1590/s0102-86502013001100008.

DOI:10.1590/s0102-86502013001100008
PMID:24316747
Abstract

PURPOSE

To determine the prevalence of non alcoholic fatty liver disease (NAFLD) and non alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery and to identify risk factors associated with the disease spectrum.

METHODS

Liver biopsy was performed in 60 patients who underwent bariatric surgery, after other causes of liver disease were excluded. Clinical, biochemical and histological features were evaluated.

RESULTS

NAFLD was detected in fifty-seven patients (95%) of the sample and forty patients (66.7%) of the total sample met the criteria for NASH. Perisinusoidal fibrosis was only found in three (7.5%) patients with NASH. The γGT was an independent predictive factor associated with the degree of hepatic steatosis. The variables such as dyslipidemia and ALT were independently associated with the presence of Mallory's corpuscles with the following values, respectively, OR 0, 05, 95% CI 0.002 to 0.75, P = 0.031 and OR 10, 99, 95% CI 1.44 to 83.93, P = 0.021.

CONCLUSIONS

Non alcoholic fatty liver disease seems to be an obese-related condition with approximately half of asymptomatic morbidly obese patients having histological NASH. The γGT was an independent predictor of the degree of steatosis.

摘要

目的

确定接受减肥手术的病态肥胖患者中非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的患病率,并识别与疾病谱相关的危险因素。

方法

在60例接受减肥手术的患者中,排除其他肝病病因后进行肝活检。评估临床、生化和组织学特征。

结果

样本中的57例患者(95%)检测出NAFLD,总样本中的40例患者(66.7%)符合NASH标准。仅在3例(7.5%)NASH患者中发现窦周纤维化。γ-谷氨酰转移酶(γGT)是与肝脂肪变性程度相关的独立预测因素。血脂异常和丙氨酸氨基转移酶(ALT)等变量分别与马洛里小体的存在独立相关,其值如下,比值比(OR)为0.05,95%置信区间(CI)为0.002至0.75,P = 0.031;OR为10.99,95%CI为1.44至83.93,P = 0.021。

结论

非酒精性脂肪性肝病似乎是一种与肥胖相关的疾病,约一半无症状的病态肥胖患者存在组织学上的NASH。γGT是脂肪变性程度的独立预测指标。

相似文献

1
The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors.病态肥胖患者非酒精性脂肪性肝病的谱:患病率及相关危险因素。
Acta Cir Bras. 2013 Nov;28(11):788-93. doi: 10.1590/s0102-86502013001100008.
2
Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.接受减肥手术的重度肥胖南印度患者中非酒精性脂肪性肝病的患病率及预测因素
Obes Surg. 2015 Nov;25(11):2078-87. doi: 10.1007/s11695-015-1655-1.
3
Hepatic histology in obese patients undergoing bariatric surgery.接受减肥手术的肥胖患者的肝脏组织学。
J Hepatol. 2006 Oct;45(4):600-6. doi: 10.1016/j.jhep.2006.06.013. Epub 2006 Jul 25.
4
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.病态肥胖的肝脏组织病理学:其他形式慢性肝病的并发情况。
Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392.
5
Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.接受减肥手术患者的非酒精性脂肪性肝病患病率及脂肪性肝炎危险因素
Obes Surg. 2015 Dec;25(12):2335-43. doi: 10.1007/s11695-015-1696-5.
6
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.肥胖症手术可减轻病态肥胖患者非酒精性脂肪性肝炎的特征。
Gastroenterology. 2015 Aug;149(2):379-88; quiz e15-6. doi: 10.1053/j.gastro.2015.04.014. Epub 2015 Apr 25.
7
Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.病态肥胖受试者的门静脉纤维化和肝脂肪变性:非酒精性脂肪性肝病的一种类型。
Hepatology. 2004 Aug;40(2):475-83. doi: 10.1002/hep.20323.
8
Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.非酒精性脂肪性肝炎和非酒精性脂肪性肝病的外科治疗。
Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7.
9
[Prevalence and associated factors to non-alcoholic steatohepatitis in obese patients subjected to bariatric surgery].[接受减肥手术的肥胖患者中非酒精性脂肪性肝炎的患病率及相关因素]
Cir Esp. 2008 Dec;84(6):313-7. doi: 10.1016/s0009-739x(08)75041-3.
10
Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients.腹腔镜减肥手术:我们还发现了什么?病态肥胖患者的肝脏病理学及晚期肝病的术前指标。
Surg Endosc. 2007 Nov;21(11):1957-60. doi: 10.1007/s00464-007-9351-4. Epub 2007 May 4.

引用本文的文献

1
Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD).代谢相关脂肪性肝病(MASLD)中的脂质代谢
Metabolites. 2023 Dec 23;14(1):12. doi: 10.3390/metabo14010012.
2
Expanding Pharmacists' Role in the Management of Non-Alcoholic Fatty Liver Disease.扩大药剂师在非酒精性脂肪性肝病管理中的作用。
Pharmacy (Basel). 2023 Sep 21;11(5):151. doi: 10.3390/pharmacy11050151.
3
BIOCHEMICAL MARKERS FOR STEATOSIS: A NECESSITY. BUT FOR NOW, BE SATISFIED WITH THE BIOPSY.脂肪变性的生化标志物:一项必要条件。但目前,活检结果即可令人满意。
Arq Bras Cir Dig. 2023 Mar 20;36:e1721. doi: 10.1590/0102-672020230002e1721. eCollection 2023.
4
The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients with Obesity.腹腔镜袖状胃切除术和胃旁路手术对伊朗肥胖患者非酒精性脂肪性肝炎的影响。
Middle East J Dig Dis. 2021 Jul;13(3):200-207. doi: 10.34172/mejdd.2021.226. Epub 2021 May 11.
5
Prevalence of Non-alcoholic Fatty Liver Disease in India: A Systematic Review and Meta-analysis.印度非酒精性脂肪性肝病的患病率:一项系统评价与荟萃分析。
J Clin Exp Hepatol. 2022 May-Jun;12(3):818-829. doi: 10.1016/j.jceh.2021.11.010. Epub 2021 Nov 25.
6
Nonalcoholic steatohepatitis: global impact and clinical consequences.非酒精性脂肪性肝炎:全球影响及临床后果
Endocr Connect. 2021 Oct 7;10(10):R240-R247. doi: 10.1530/EC-21-0048.
7
Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病肥胖患者无创性肝纤维化检测的性能。
Obes Surg. 2021 May;31(5):2002-2010. doi: 10.1007/s11695-020-04996-1. Epub 2021 Feb 22.
8
HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels.糖化血红蛋白即使在正常范围内也可能导致非酒精性脂肪性肝病的发生。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20193996.
9
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.非酒精性脂肪性肝病相关肝细胞癌:日益受到关注。
Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17.
10
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.